FHAM
INSY

Folger Hill Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Folger Hill Asset Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,700
Closed -$267K – 248
2016
Q1 		$267K Buy
+16,700
New +$317K 0.02% 162

Other funds holding INSY

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Folger Hill Asset Management's INSY Position: Q4 2017 in Review

Folger Hill Asset Management sold out of Insys Therapeutics, Inc. (INSY) in Q4 2017, closing a stake of 396,315 shares — an estimated $3.52M sold.

Folger Hill Asset Management first reported a position in INSY in Q4 2015 and held it in 8 quarters. The position peaked at $28.6M in Q4 2015. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2017.

  • Folger Hill Asset Management reported no remaining Insys Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 396,315 Insys Therapeutics, Inc. shares in Q4 2017, an estimated $3.52M.
  • Folger Hill Asset Management first reported a position in Insys Therapeutics, Inc. in Q4 2015 and held it in 8 quarters.
  • Folger Hill Asset Management's Insys Therapeutics, Inc. position peaked at $28.6M in Q4 2015.
  • 113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2017.

Based on Folger Hill Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.